Bank of Montreal’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History

Bank of Montreal’s Portfolio FTXH Stock Details FTXH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$317K	Hold	9,214	–	–	﹤0.01%	2647
2025 Q4	$304K	Sell	9,214 -10	-0.1%	-$312	﹤0.01%	2581
2025 Q3	$263K	Buy	9,224 +1,003	+12%	+$27.3K	﹤0.01%	2599
2025 Q2	$211K	Buy	8,221 +3,333	+68%	+$84.4K	﹤0.01%	2781
2025 Q1	$134K	Hold	4,888	–	–	﹤0.01%	2848
2024 Q4	$132K	Hold	4,888	–	–	﹤0.01%	2880
2024 Q3	$140K	Hold	4,888	–	–	﹤0.01%	3149
2024 Q2	$136K	Sell	4,888 -1,081	-18%	-$29K	﹤0.01%	3154
2024 Q1	$168K	Hold	5,969	–	–	﹤0.01%	3123
2023 Q4	$159K	Buy	+5,969	New	+$150K	﹤0.01%	3219

Other funds holding FTXH

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

MIM

Marshall Investment Management Littleton, Colorado $208M AUM 30.96% 1-Year Est. Return

Oppenheimer & Co New York $8.21B AUM 28.81% 1-Year Est. Return

AIP

Ameritas Investment Partners Lincoln, Nebraska $3.25B AUM 28.52% 1-Year Est. Return

Nilsine Partners Greenwood Village, Colorado $1.45B AUM 47.06% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $43.3B AUM 29.3% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

VCM

Vivaldi Capital Management Chicago, Illinois $723M AUM 30.89% 1-Year Est. Return

Bank of Montreal's FTXH Position: Q1 2026 in Review

Bank of Montreal held its First Trust Nasdaq Pharmaceuticals ETF (FTXH) position steady in Q1 2026 at 9,214 shares worth $317K. The position accounts for ﹤0.01% of the portfolio, ranked #2647.

Bank of Montreal first reported a position in FTXH in Q4 2023 and has held it in 10 quarters since. 32 funds tracked by Wall St. Rank hold FTXH as of Q1 2026.

Bank of Montreal held 9,214 shares of First Trust Nasdaq Pharmaceuticals ETF worth $317K as of Q1 2026.
Bank of Montreal left its First Trust Nasdaq Pharmaceuticals ETF share count unchanged in Q1 2026.
First Trust Nasdaq Pharmaceuticals ETF made up ﹤0.01% of Bank of Montreal's portfolio in Q1 2026, its #2647 holding.
Bank of Montreal first reported a position in First Trust Nasdaq Pharmaceuticals ETF in Q4 2023 and has held it in 10 quarters since.
32 funds tracked by Wall St. Rank held First Trust Nasdaq Pharmaceuticals ETF as of Q1 2026.

Based on Bank of Montreal's 13F filing for Q1 2026, filed 13 May 2026.